Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MSCs for Tolerance in Deceased Donor Kidney Transplant
NCT02565459Phase 1Unknown
- Start
- Sep 2015
- Primary completion
- Sep 2021
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Provacel in kidney transplantation. Primary endpoints: Number of adverse events at 12 months and Circulating naive and memory T cell count (CD45RA/CD45RO) at 12 months. Status: unknown.
02
Drugs
Provacel
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT02565459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02565459.